Bank of America
PMVP icon

Bank of America’s PMV Pharmaceuticals PMVP Stock Holding History

Bank of America’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$298K Buy
240,531
+393
+0.2% +$500 ﹤0.01% 5159
2025
Q4 		$300K Buy
240,138
+77,642
+48% +$104K ﹤0.01% 5157
2025
Q3 		$227K Buy
162,496
+133,349
+458% +$184K ﹤0.01% 6218
2025
Q2 		$30.9K Sell
29,147
-5,559
-16% -$5.45K ﹤0.01% 6949
2025
Q1 		$37.8K Sell
34,706
-9,862
-22% -$13.4K ﹤0.01% 6813
2024
Q4 		$67.3K Sell
44,568
-76,202
-63% -$121K ﹤0.01% 6544
2024
Q3 		$180K Sell
120,770
-219,616
-65% -$339K ﹤0.01% 6061
2024
Q2 		$551K Sell
340,386
-1,027,529
-75% -$1.85M ﹤0.01% 5279
2024
Q1 		$2.33M Sell
1,367,915
-71,926
-5% -$134K ﹤0.01% 4324
2023
Q4 		$4.46M Buy
1,439,841
+1,290,912
+867% +$3.42M ﹤0.01% 3644
2023
Q3 		$914K Sell
148,929
-46,988
-24% -$323K ﹤0.01% 4879
2023
Q2 		$1.23M Sell
195,917
-735,781
-79% -$3.86M ﹤0.01% 4615
2023
Q1 		$4.44M Sell
931,698
-83,518
-8% -$588K ﹤0.01% 3640
2022
Q4 		$8.83M Buy
1,015,216
+540,845
+114% +$5.76M ﹤0.01% 2812
2022
Q3 		$5.64M Buy
474,371
+42,445
+10% +$613K ﹤0.01% 3218
2022
Q2 		$6.16M Buy
431,926
+175,089
+68% +$2.55M ﹤0.01% 3166
2022
Q1 		$5.35M Buy
256,837
+183,018
+248% +$3.23M ﹤0.01% 3546
2021
Q4 		$1.71M Buy
73,819
+46,850
+174% +$1.13M ﹤0.01% 4718
2021
Q3 		$804K Sell
26,969
-13,050
-33% -$417K ﹤0.01% 5267
2021
Q2 		$1.37M Buy
40,019
+1,273
+3% +$42.5K ﹤0.01% 4638
2021
Q1 		$1.27M Buy
38,746
+34,300
+771% +$1.35M ﹤0.01% 4631
2020
Q4 		$273K Buy
4,446
+4,146
+1,382% +$163K ﹤0.01% 5394
2020
Q3 		$11K Buy
+300
New +$11K ﹤0.01% 6430

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bank of America's PMVP Position: Q1 2026 in Review

Bank of America increased its PMV Pharmaceuticals (PMVP) stake by 0.16% in Q1 2026, buying an estimated $500 and bringing the position to 240,531 shares worth $298K. The position accounts for ﹤0.01% of the portfolio, ranked #5159.

Bank of America first reported a position in PMVP in Q3 2020 and has held it in 23 quarters since. The position peaked at $8.83M in Q4 2022. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Bank of America held 240,531 shares of PMV Pharmaceuticals worth $298K as of Q1 2026.
  • Bank of America bought 393 PMV Pharmaceuticals shares in Q1 2026, an estimated $500.
  • PMV Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5159 holding.
  • Bank of America first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
  • Bank of America's PMV Pharmaceuticals position peaked at $8.83M in Q4 2022.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.